nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—ATP7B—head and neck cancer	0.197	0.644	CbGaD
Cisplatin—esophageal cancer—head and neck cancer	0.142	0.356	CtDrD
Cisplatin—bone cancer—head and neck cancer	0.102	0.255	CtDrD
Cisplatin—GSTM1—head and neck cancer	0.0842	0.275	CbGaD
Cisplatin—germ cell cancer—head and neck cancer	0.0807	0.203	CtDrD
Cisplatin—peripheral nervous system neoplasm—head and neck cancer	0.0744	0.187	CtDrD
Cisplatin—ABCC6—Vinblastine—head and neck cancer	0.0515	0.278	CbGbCtD
Cisplatin—ABCC5—Fluorouracil—head and neck cancer	0.0425	0.229	CbGbCtD
Cisplatin—ABCC3—Fluorouracil—head and neck cancer	0.0267	0.144	CbGbCtD
Cisplatin—PTGS2—head and neck cancer	0.0246	0.0805	CbGaD
Cisplatin—SLC22A2—Vinblastine—head and neck cancer	0.0138	0.0744	CbGbCtD
Cisplatin—ABCC2—Vinblastine—head and neck cancer	0.0112	0.0607	CbGbCtD
Cisplatin—ABCG2—Fluorouracil—head and neck cancer	0.011	0.0593	CbGbCtD
Cisplatin—ABCC2—Docetaxel—head and neck cancer	0.00927	0.0501	CbGbCtD
Cisplatin—ABCG2—Docetaxel—head and neck cancer	0.00838	0.0453	CbGbCtD
Cisplatin—CYP2C9—Fluorouracil—head and neck cancer	0.00408	0.022	CbGbCtD
Cisplatin—ABCB1—Vinblastine—head and neck cancer	0.00367	0.0198	CbGbCtD
Cisplatin—ABCB1—Docetaxel—head and neck cancer	0.00302	0.0163	CbGbCtD
Cisplatin—Urine output—Hydroxyurea—head and neck cancer	0.00188	0.0443	CcSEcCtD
Cisplatin—Ocular toxicity—Fluorouracil—head and neck cancer	0.00173	0.0408	CcSEcCtD
Cisplatin—Metastatic neoplasm—Hydroxyurea—head and neck cancer	0.0017	0.04	CcSEcCtD
Cisplatin—Gastrointestinal ulcer haemorrhage—Fluorouracil—head and neck cancer	0.00122	0.0288	CcSEcCtD
Cisplatin—Azoospermia—Hydroxyurea—head and neck cancer	0.00121	0.0285	CcSEcCtD
Cisplatin—Fibrosis—Hydroxyurea—head and neck cancer	0.00114	0.0269	CcSEcCtD
Cisplatin—NQO1—Vincristine—Vinblastine—head and neck cancer	0.00104	1	CbGdCrCtD
Cisplatin—Skin necrosis—Hydroxyurea—head and neck cancer	0.000933	0.022	CcSEcCtD
Cisplatin—Metastatic neoplasm—Docetaxel—head and neck cancer	0.000883	0.0208	CcSEcCtD
Cisplatin—Ototoxicity—Docetaxel—head and neck cancer	0.000844	0.0199	CcSEcCtD
Cisplatin—Fibrosis—Fluorouracil—head and neck cancer	0.000821	0.0193	CcSEcCtD
Cisplatin—SLC31A2—exocrine gland—head and neck cancer	0.00082	0.0307	CbGeAlD
Cisplatin—Memory loss—Fluorouracil—head and neck cancer	0.000798	0.0188	CcSEcCtD
Cisplatin—SLC31A2—hair follicle—head and neck cancer	0.000782	0.0293	CbGeAlD
Cisplatin—MPO—saliva—head and neck cancer	0.000767	0.0287	CbGeAlD
Cisplatin—Myelosuppression—Vinblastine—head and neck cancer	0.000762	0.0179	CcSEcCtD
Cisplatin—MT1A—mouth—head and neck cancer	0.000749	0.0281	CbGeAlD
Cisplatin—Myelosuppression—Hydroxyurea—head and neck cancer	0.000695	0.0164	CcSEcCtD
Cisplatin—ATP7A—hair follicle—head and neck cancer	0.000689	0.0258	CbGeAlD
Cisplatin—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.000615	0.0145	CcSEcCtD
Cisplatin—SLC31A2—mouth—head and neck cancer	0.000613	0.023	CbGeAlD
Cisplatin—GSTT1—mouth—head and neck cancer	0.000611	0.0229	CbGeAlD
Cisplatin—SOD1—hair follicle—head and neck cancer	0.000603	0.0226	CbGeAlD
Cisplatin—Acute leukaemia—Docetaxel—head and neck cancer	0.000592	0.014	CcSEcCtD
Cisplatin—SLC31A1—hair follicle—head and neck cancer	0.000587	0.022	CbGeAlD
Cisplatin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000542	0.0128	CcSEcCtD
Cisplatin—Slurred speech—Fluorouracil—head and neck cancer	0.000525	0.0124	CcSEcCtD
Cisplatin—GSTT1—neck—head and neck cancer	0.000522	0.0196	CbGeAlD
Cisplatin—Myelosuppression—Fluorouracil—head and neck cancer	0.0005	0.0118	CcSEcCtD
Cisplatin—MT1A—connective tissue—head and neck cancer	0.000459	0.0172	CbGeAlD
Cisplatin—GSTM1—mouth—head and neck cancer	0.00045	0.0169	CbGeAlD
Cisplatin—Neurotoxicity—Docetaxel—head and neck cancer	0.000437	0.0103	CcSEcCtD
Cisplatin—ABCC5—hair follicle—head and neck cancer	0.00043	0.0161	CbGeAlD
Cisplatin—SLC31A2—parotid gland—head and neck cancer	0.000427	0.016	CbGeAlD
Cisplatin—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000422	0.00994	CcSEcCtD
Cisplatin—Extravasation—Vinblastine—head and neck cancer	0.00041	0.00965	CcSEcCtD
Cisplatin—SLC31A2—saliva-secreting gland—head and neck cancer	0.000409	0.0153	CbGeAlD
Cisplatin—Cellulitis—Vinblastine—head and neck cancer	0.000393	0.00926	CcSEcCtD
Cisplatin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00039	0.00918	CcSEcCtD
Cisplatin—GSTM1—neck—head and neck cancer	0.000385	0.0144	CbGeAlD
Cisplatin—MT2A—connective tissue—head and neck cancer	0.000382	0.0143	CbGeAlD
Cisplatin—GSTP1—exocrine gland—head and neck cancer	0.000377	0.0141	CbGeAlD
Cisplatin—ATP7A—parotid gland—head and neck cancer	0.000376	0.0141	CbGeAlD
Cisplatin—Tenderness—Hydroxyurea—head and neck cancer	0.000374	0.0088	CcSEcCtD
Cisplatin—Myelosuppression—Docetaxel—head and neck cancer	0.000361	0.0085	CcSEcCtD
Cisplatin—ATP7A—saliva-secreting gland—head and neck cancer	0.00036	0.0135	CbGeAlD
Cisplatin—GSTP1—hair follicle—head and neck cancer	0.000359	0.0135	CbGeAlD
Cisplatin—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000351	0.00827	CcSEcCtD
Cisplatin—ATP7B—trachea—head and neck cancer	0.000345	0.0129	CbGeAlD
Cisplatin—Ulcer—Hydroxyurea—head and neck cancer	0.000345	0.00812	CcSEcCtD
Cisplatin—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000332	0.00782	CcSEcCtD
Cisplatin—ATP7A—connective tissue—head and neck cancer	0.000331	0.0124	CbGeAlD
Cisplatin—SOD1—parotid gland—head and neck cancer	0.000329	0.0123	CbGeAlD
Cisplatin—PTGS2—cartilage tissue—head and neck cancer	0.000324	0.0121	CbGeAlD
Cisplatin—SLC31A1—parotid gland—head and neck cancer	0.000321	0.012	CbGeAlD
Cisplatin—SLC31A2—trachea—head and neck cancer	0.000316	0.0118	CbGeAlD
Cisplatin—SOD1—saliva-secreting gland—head and neck cancer	0.000315	0.0118	CbGeAlD
Cisplatin—NQO1—mouth—head and neck cancer	0.000315	0.0118	CbGeAlD
Cisplatin—ATP7A—epithelium—head and neck cancer	0.000314	0.0118	CbGeAlD
Cisplatin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000311	0.00733	CcSEcCtD
Cisplatin—SLC31A1—saliva-secreting gland—head and neck cancer	0.000307	0.0115	CbGeAlD
Cisplatin—MT1A—thyroid gland—head and neck cancer	0.000305	0.0114	CbGeAlD
Cisplatin—ABCC6—connective tissue—head and neck cancer	0.000304	0.0114	CbGeAlD
Cisplatin—Phlebitis—Vinblastine—head and neck cancer	0.000301	0.00709	CcSEcCtD
Cisplatin—Necrosis—Fluorouracil—head and neck cancer	0.000299	0.00704	CcSEcCtD
Cisplatin—Deafness—Vinblastine—head and neck cancer	0.00029	0.00683	CcSEcCtD
Cisplatin—GSTP1—mouth—head and neck cancer	0.000282	0.0106	CbGeAlD
Cisplatin—Febrile neutropenia—Docetaxel—head and neck cancer	0.000281	0.00663	CcSEcCtD
Cisplatin—MT2A—lymphoid tissue—head and neck cancer	0.00028	0.0105	CbGeAlD
Cisplatin—ATP7A—trachea—head and neck cancer	0.000278	0.0104	CbGeAlD
Cisplatin—GSTM1—connective tissue—head and neck cancer	0.000276	0.0103	CbGeAlD
Cisplatin—GSTT1—lymphoid tissue—head and neck cancer	0.000274	0.0103	CbGeAlD
Cisplatin—NQO1—neck—head and neck cancer	0.00027	0.0101	CbGeAlD
Cisplatin—Extravasation—Fluorouracil—head and neck cancer	0.000269	0.00633	CcSEcCtD
Cisplatin—Tenderness—Fluorouracil—head and neck cancer	0.000269	0.00633	CcSEcCtD
Cisplatin—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000265	0.00623	CcSEcCtD
Cisplatin—Cellulitis—Fluorouracil—head and neck cancer	0.000258	0.00608	CcSEcCtD
Cisplatin—Renal failure acute—Hydroxyurea—head and neck cancer	0.000256	0.00604	CcSEcCtD
Cisplatin—SLC31A2—thyroid gland—head and neck cancer	0.00025	0.00935	CbGeAlD
Cisplatin—GSTT1—thyroid gland—head and neck cancer	0.000249	0.00932	CbGeAlD
Cisplatin—Ulcer—Fluorouracil—head and neck cancer	0.000248	0.00584	CcSEcCtD
Cisplatin—Dysarthria—Fluorouracil—head and neck cancer	0.000248	0.00584	CcSEcCtD
Cisplatin—SOD1—trachea—head and neck cancer	0.000243	0.00912	CbGeAlD
Cisplatin—ATP7B—head—head and neck cancer	0.000242	0.00908	CbGeAlD
Cisplatin—GSTP1—neck—head and neck cancer	0.000241	0.00903	CbGeAlD
Cisplatin—SLC31A1—trachea—head and neck cancer	0.000237	0.00889	CbGeAlD
Cisplatin—Face oedema—Hydroxyurea—head and neck cancer	0.000228	0.00538	CcSEcCtD
Cisplatin—MT2A—head—head and neck cancer	0.000225	0.00844	CbGeAlD
Cisplatin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000222	0.00522	CcSEcCtD
Cisplatin—SLC31A2—head—head and neck cancer	0.000221	0.0083	CbGeAlD
Cisplatin—GSTT1—head—head and neck cancer	0.000221	0.00826	CbGeAlD
Cisplatin—ATP7A—thyroid gland—head and neck cancer	0.00022	0.00824	CbGeAlD
Cisplatin—NQO1—parotid gland—head and neck cancer	0.00022	0.00823	CbGeAlD
Cisplatin—Hepatotoxicity—Docetaxel—head and neck cancer	0.000219	0.00516	CcSEcCtD
Cisplatin—Necrosis—Docetaxel—head and neck cancer	0.000216	0.00508	CcSEcCtD
Cisplatin—Breast disorder—Hydroxyurea—head and neck cancer	0.000214	0.00504	CcSEcCtD
Cisplatin—Pancytopenia—Vinblastine—head and neck cancer	0.000213	0.00501	CcSEcCtD
Cisplatin—NQO1—saliva-secreting gland—head and neck cancer	0.00021	0.00788	CbGeAlD
Cisplatin—Ageusia—Docetaxel—head and neck cancer	0.000209	0.00492	CcSEcCtD
Cisplatin—Rhinorrhoea—Docetaxel—head and neck cancer	0.000209	0.00492	CcSEcCtD
Cisplatin—ABCC6—thyroid gland—head and neck cancer	0.000202	0.00756	CbGeAlD
Cisplatin—GSTM1—lymphoid tissue—head and neck cancer	0.000202	0.00755	CbGeAlD
Cisplatin—Pancreatitis—Hydroxyurea—head and neck cancer	0.0002	0.00472	CcSEcCtD
Cisplatin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000197	0.00464	CcSEcCtD
Cisplatin—GSTP1—parotid gland—head and neck cancer	0.000196	0.00735	CbGeAlD
Cisplatin—Myocardial infarction—Vinblastine—head and neck cancer	0.000196	0.00462	CcSEcCtD
Cisplatin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000196	0.00462	CcSEcCtD
Cisplatin—Pancytopenia—Hydroxyurea—head and neck cancer	0.000194	0.00457	CcSEcCtD
Cisplatin—Extravasation—Docetaxel—head and neck cancer	0.000194	0.00457	CcSEcCtD
Cisplatin—NQO1—connective tissue—head and neck cancer	0.000193	0.00724	CbGeAlD
Cisplatin—SOD1—thyroid gland—head and neck cancer	0.000193	0.00721	CbGeAlD
Cisplatin—MT1A—lymph node—head and neck cancer	0.000189	0.0071	CbGeAlD
Cisplatin—GSTP1—saliva-secreting gland—head and neck cancer	0.000188	0.00704	CbGeAlD
Cisplatin—SLC31A1—thyroid gland—head and neck cancer	0.000188	0.00703	CbGeAlD
Cisplatin—NQO1—epithelium—head and neck cancer	0.000183	0.00688	CbGeAlD
Cisplatin—GSTM1—thyroid gland—head and neck cancer	0.000183	0.00686	CbGeAlD
Cisplatin—Amnesia—Fluorouracil—head and neck cancer	0.000181	0.00427	CcSEcCtD
Cisplatin—ABCC6—head—head and neck cancer	0.000179	0.00671	CbGeAlD
Cisplatin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000179	0.00421	CcSEcCtD
Cisplatin—Hearing impaired—Docetaxel—head and neck cancer	0.000178	0.00419	CcSEcCtD
Cisplatin—Stomatitis—Hydroxyurea—head and neck cancer	0.000178	0.00419	CcSEcCtD
Cisplatin—MPO—connective tissue—head and neck cancer	0.000178	0.00666	CbGeAlD
Cisplatin—GSTP1—connective tissue—head and neck cancer	0.000173	0.00647	CbGeAlD
Cisplatin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000172	0.00406	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00017	0.00401	CcSEcCtD
Cisplatin—ATP7B—lymph node—head and neck cancer	0.00017	0.00636	CbGeAlD
Cisplatin—Hepatocellular injury—Docetaxel—head and neck cancer	0.000169	0.00399	CcSEcCtD
Cisplatin—MPO—epithelium—head and neck cancer	0.000169	0.00632	CbGeAlD
Cisplatin—SLC31A1—head—head and neck cancer	0.000166	0.00624	CbGeAlD
Cisplatin—GSTP1—epithelium—head and neck cancer	0.000164	0.00614	CbGeAlD
Cisplatin—Irritability—Fluorouracil—head and neck cancer	0.000163	0.00383	CcSEcCtD
Cisplatin—GSTM1—head—head and neck cancer	0.000162	0.00609	CbGeAlD
Cisplatin—NQO1—trachea—head and neck cancer	0.000162	0.00608	CbGeAlD
Cisplatin—Skin exfoliation—Docetaxel—head and neck cancer	0.000162	0.00381	CcSEcCtD
Cisplatin—Fluid retention—Docetaxel—head and neck cancer	0.000161	0.00379	CcSEcCtD
Cisplatin—Neuropathy—Docetaxel—head and neck cancer	0.000159	0.00374	CcSEcCtD
Cisplatin—Alopecia—Vinblastine—head and neck cancer	0.000159	0.00373	CcSEcCtD
Cisplatin—SLC31A2—lymph node—head and neck cancer	0.000155	0.00581	CbGeAlD
Cisplatin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000152	0.00359	CcSEcCtD
Cisplatin—GSTP1—trachea—head and neck cancer	0.000145	0.00543	CbGeAlD
Cisplatin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000145	0.00341	CcSEcCtD
Cisplatin—Alopecia—Hydroxyurea—head and neck cancer	0.000145	0.00341	CcSEcCtD
Cisplatin—Anaemia—Vinblastine—head and neck cancer	0.000144	0.0034	CcSEcCtD
Cisplatin—Phlebitis—Docetaxel—head and neck cancer	0.000143	0.00336	CcSEcCtD
Cisplatin—Erythema—Hydroxyurea—head and neck cancer	0.000142	0.00336	CcSEcCtD
Cisplatin—Malaise—Vinblastine—head and neck cancer	0.000141	0.00332	CcSEcCtD
Cisplatin—Leukopenia—Vinblastine—head and neck cancer	0.00014	0.00329	CcSEcCtD
Cisplatin—Pancytopenia—Fluorouracil—head and neck cancer	0.00014	0.00329	CcSEcCtD
Cisplatin—Deafness—Docetaxel—head and neck cancer	0.000137	0.00324	CcSEcCtD
Cisplatin—ABCC5—thyroid gland—head and neck cancer	0.000137	0.00514	CbGeAlD
Cisplatin—ATP7A—lymph node—head and neck cancer	0.000137	0.00512	CbGeAlD
Cisplatin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000136	0.00319	CcSEcCtD
Cisplatin—Convulsion—Vinblastine—head and neck cancer	0.000135	0.00319	CcSEcCtD
Cisplatin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000132	0.00311	CcSEcCtD
Cisplatin—Anaemia—Hydroxyurea—head and neck cancer	0.000132	0.0031	CcSEcCtD
Cisplatin—PTGS2—mouth—head and neck cancer	0.000131	0.00493	CbGeAlD
Cisplatin—Discomfort—Vinblastine—head and neck cancer	0.000131	0.00309	CcSEcCtD
Cisplatin—MPO—lymphoid tissue—head and neck cancer	0.00013	0.00487	CbGeAlD
Cisplatin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000129	0.00305	CcSEcCtD
Cisplatin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000129	0.00303	CcSEcCtD
Cisplatin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000129	0.00303	CcSEcCtD
Cisplatin—Malaise—Hydroxyurea—head and neck cancer	0.000128	0.00303	CcSEcCtD
Cisplatin—NQO1—thyroid gland—head and neck cancer	0.000128	0.00481	CbGeAlD
Cisplatin—Stomatitis—Fluorouracil—head and neck cancer	0.000128	0.00301	CcSEcCtD
Cisplatin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000128	0.003	CcSEcCtD
Cisplatin—Leukopenia—Hydroxyurea—head and neck cancer	0.000128	0.003	CcSEcCtD
Cisplatin—GSTP1—lymphoid tissue—head and neck cancer	0.000126	0.00473	CbGeAlD
Cisplatin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000125	0.00294	CcSEcCtD
Cisplatin—Convulsion—Hydroxyurea—head and neck cancer	0.000123	0.00291	CcSEcCtD
Cisplatin—Hyponatraemia—Docetaxel—head and neck cancer	0.000123	0.00291	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000123	0.00289	CcSEcCtD
Cisplatin—Anorexia—Vinblastine—head and neck cancer	0.000122	0.00286	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00012	0.00284	CcSEcCtD
Cisplatin—Discomfort—Hydroxyurea—head and neck cancer	0.00012	0.00282	CcSEcCtD
Cisplatin—SOD1—lymph node—head and neck cancer	0.00012	0.00448	CbGeAlD
Cisplatin—SLC31A1—lymph node—head and neck cancer	0.000117	0.00437	CbGeAlD
Cisplatin—Oedema—Hydroxyurea—head and neck cancer	0.000116	0.00274	CcSEcCtD
Cisplatin—Infection—Hydroxyurea—head and neck cancer	0.000116	0.00272	CcSEcCtD
Cisplatin—ABCC3—thyroid gland—head and neck cancer	0.000115	0.00432	CbGeAlD
Cisplatin—ABCG2—parotid gland—head and neck cancer	0.000115	0.0043	CbGeAlD
Cisplatin—GSTP1—thyroid gland—head and neck cancer	0.000115	0.0043	CbGeAlD
Cisplatin—Paraesthesia—Vinblastine—head and neck cancer	0.000114	0.0027	CcSEcCtD
Cisplatin—Dehydration—Docetaxel—head and neck cancer	0.000114	0.00269	CcSEcCtD
Cisplatin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000114	0.00269	CcSEcCtD
Cisplatin—NQO1—head—head and neck cancer	0.000114	0.00427	CbGeAlD
Cisplatin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000114	0.00268	CcSEcCtD
Cisplatin—GSTM1—lymph node—head and neck cancer	0.000114	0.00426	CbGeAlD
Cisplatin—Skin disorder—Hydroxyurea—head and neck cancer	0.000113	0.00266	CcSEcCtD
Cisplatin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000112	0.00264	CcSEcCtD
Cisplatin—Breast disorder—Docetaxel—head and neck cancer	0.000111	0.00262	CcSEcCtD
Cisplatin—Anorexia—Hydroxyurea—head and neck cancer	0.000111	0.00261	CcSEcCtD
Cisplatin—Decreased appetite—Vinblastine—head and neck cancer	0.000111	0.00261	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000111	0.00261	CcSEcCtD
Cisplatin—Cramp muscle—Docetaxel—head and neck cancer	0.000111	0.00261	CcSEcCtD
Cisplatin—ABCG2—saliva-secreting gland—head and neck cancer	0.00011	0.00412	CbGeAlD
Cisplatin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00011	0.00259	CcSEcCtD
Cisplatin—Pain—Vinblastine—head and neck cancer	0.000109	0.00257	CcSEcCtD
Cisplatin—Arrhythmia—Fluorouracil—head and neck cancer	0.000105	0.00248	CcSEcCtD
Cisplatin—Feeling abnormal—Vinblastine—head and neck cancer	0.000105	0.00247	CcSEcCtD
Cisplatin—MPO—head—head and neck cancer	0.000105	0.00392	CbGeAlD
Cisplatin—Alopecia—Fluorouracil—head and neck cancer	0.000104	0.00245	CcSEcCtD
Cisplatin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000104	0.00244	CcSEcCtD
Cisplatin—Erythema—Fluorouracil—head and neck cancer	0.000103	0.00242	CcSEcCtD
Cisplatin—ABCC3—head—head and neck cancer	0.000102	0.00383	CbGeAlD
Cisplatin—GSTP1—head—head and neck cancer	0.000102	0.00381	CbGeAlD
Cisplatin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000101	0.00238	CcSEcCtD
Cisplatin—Pancytopenia—Docetaxel—head and neck cancer	0.000101	0.00238	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0001	0.00236	CcSEcCtD
Cisplatin—Pain—Hydroxyurea—head and neck cancer	9.94e-05	0.00234	CcSEcCtD
Cisplatin—Vision blurred—Fluorouracil—head and neck cancer	9.66e-05	0.00228	CcSEcCtD
Cisplatin—Feeling abnormal—Hydroxyurea—head and neck cancer	9.58e-05	0.00226	CcSEcCtD
Cisplatin—Anaemia—Fluorouracil—head and neck cancer	9.48e-05	0.00223	CcSEcCtD
Cisplatin—Hypersensitivity—Vinblastine—head and neck cancer	9.39e-05	0.00221	CcSEcCtD
Cisplatin—Acute coronary syndrome—Docetaxel—head and neck cancer	9.34e-05	0.0022	CcSEcCtD
Cisplatin—Renal failure—Docetaxel—head and neck cancer	9.31e-05	0.00219	CcSEcCtD
Cisplatin—Neuropathy peripheral—Docetaxel—head and neck cancer	9.28e-05	0.00219	CcSEcCtD
Cisplatin—Myocardial infarction—Docetaxel—head and neck cancer	9.28e-05	0.00219	CcSEcCtD
Cisplatin—Stomatitis—Docetaxel—head and neck cancer	9.23e-05	0.00217	CcSEcCtD
Cisplatin—Conjunctivitis—Docetaxel—head and neck cancer	9.21e-05	0.00217	CcSEcCtD
Cisplatin—Body temperature increased—Hydroxyurea—head and neck cancer	9.19e-05	0.00216	CcSEcCtD
Cisplatin—Leukopenia—Fluorouracil—head and neck cancer	9.18e-05	0.00216	CcSEcCtD
Cisplatin—Asthenia—Vinblastine—head and neck cancer	9.15e-05	0.00215	CcSEcCtD
Cisplatin—Hepatobiliary disease—Docetaxel—head and neck cancer	8.96e-05	0.00211	CcSEcCtD
Cisplatin—Convulsion—Fluorouracil—head and neck cancer	8.88e-05	0.00209	CcSEcCtD
Cisplatin—BCHE—trachea—head and neck cancer	8.78e-05	0.00329	CbGeAlD
Cisplatin—Myalgia—Fluorouracil—head and neck cancer	8.73e-05	0.00206	CcSEcCtD
Cisplatin—Diarrhoea—Vinblastine—head and neck cancer	8.72e-05	0.00205	CcSEcCtD
Cisplatin—Discomfort—Fluorouracil—head and neck cancer	8.63e-05	0.00203	CcSEcCtD
Cisplatin—Hypersensitivity—Hydroxyurea—head and neck cancer	8.57e-05	0.00202	CcSEcCtD
Cisplatin—ABCC5—lymph node—head and neck cancer	8.52e-05	0.00319	CbGeAlD
Cisplatin—Urinary tract disorder—Docetaxel—head and neck cancer	8.4e-05	0.00198	CcSEcCtD
Cisplatin—Oedema—Fluorouracil—head and neck cancer	8.37e-05	0.00197	CcSEcCtD
Cisplatin—Anaphylactic shock—Fluorouracil—head and neck cancer	8.37e-05	0.00197	CcSEcCtD
Cisplatin—Connective tissue disorder—Docetaxel—head and neck cancer	8.35e-05	0.00197	CcSEcCtD
Cisplatin—Asthenia—Hydroxyurea—head and neck cancer	8.34e-05	0.00196	CcSEcCtD
Cisplatin—Urethral disorder—Docetaxel—head and neck cancer	8.33e-05	0.00196	CcSEcCtD
Cisplatin—Infection—Fluorouracil—head and neck cancer	8.31e-05	0.00196	CcSEcCtD
Cisplatin—Nervous system disorder—Fluorouracil—head and neck cancer	8.21e-05	0.00193	CcSEcCtD
Cisplatin—Thrombocytopenia—Fluorouracil—head and neck cancer	8.19e-05	0.00193	CcSEcCtD
Cisplatin—Visual impairment—Docetaxel—head and neck cancer	8.19e-05	0.00193	CcSEcCtD
Cisplatin—Tachycardia—Fluorouracil—head and neck cancer	8.17e-05	0.00192	CcSEcCtD
Cisplatin—Vomiting—Vinblastine—head and neck cancer	8.11e-05	0.00191	CcSEcCtD
Cisplatin—PTGS2—connective tissue—head and neck cancer	8.06e-05	0.00302	CbGeAlD
Cisplatin—Anorexia—Fluorouracil—head and neck cancer	7.98e-05	0.00188	CcSEcCtD
Cisplatin—NQO1—lymph node—head and neck cancer	7.97e-05	0.00299	CbGeAlD
Cisplatin—Diarrhoea—Hydroxyurea—head and neck cancer	7.96e-05	0.00187	CcSEcCtD
Cisplatin—Eye disorder—Docetaxel—head and neck cancer	7.95e-05	0.00187	CcSEcCtD
Cisplatin—Flushing—Docetaxel—head and neck cancer	7.89e-05	0.00186	CcSEcCtD
Cisplatin—Cardiac disorder—Docetaxel—head and neck cancer	7.89e-05	0.00186	CcSEcCtD
Cisplatin—Hypotension—Fluorouracil—head and neck cancer	7.82e-05	0.00184	CcSEcCtD
Cisplatin—Immune system disorder—Docetaxel—head and neck cancer	7.68e-05	0.00181	CcSEcCtD
Cisplatin—Mediastinal disorder—Docetaxel—head and neck cancer	7.66e-05	0.0018	CcSEcCtD
Cisplatin—PTGS2—epithelium—head and neck cancer	7.65e-05	0.00287	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.62e-05	0.0018	CcSEcCtD
Cisplatin—Arrhythmia—Docetaxel—head and neck cancer	7.6e-05	0.00179	CcSEcCtD
Cisplatin—Nausea—Vinblastine—head and neck cancer	7.57e-05	0.00178	CcSEcCtD
Cisplatin—Paraesthesia—Fluorouracil—head and neck cancer	7.51e-05	0.00177	CcSEcCtD
Cisplatin—Alopecia—Docetaxel—head and neck cancer	7.51e-05	0.00177	CcSEcCtD
Cisplatin—Dyspnoea—Fluorouracil—head and neck cancer	7.46e-05	0.00176	CcSEcCtD
Cisplatin—Malnutrition—Docetaxel—head and neck cancer	7.4e-05	0.00174	CcSEcCtD
Cisplatin—Erythema—Docetaxel—head and neck cancer	7.4e-05	0.00174	CcSEcCtD
Cisplatin—Vomiting—Hydroxyurea—head and neck cancer	7.39e-05	0.00174	CcSEcCtD
Cisplatin—Rash—Hydroxyurea—head and neck cancer	7.33e-05	0.00173	CcSEcCtD
Cisplatin—MPO—lymph node—head and neck cancer	7.33e-05	0.00275	CbGeAlD
Cisplatin—Dermatitis—Hydroxyurea—head and neck cancer	7.32e-05	0.00173	CcSEcCtD
Cisplatin—Decreased appetite—Fluorouracil—head and neck cancer	7.28e-05	0.00171	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7.23e-05	0.0017	CcSEcCtD
Cisplatin—Pain—Fluorouracil—head and neck cancer	7.16e-05	0.00169	CcSEcCtD
Cisplatin—ABCC3—lymph node—head and neck cancer	7.16e-05	0.00268	CbGeAlD
Cisplatin—GSTP1—lymph node—head and neck cancer	7.12e-05	0.00267	CbGeAlD
Cisplatin—Muscle spasms—Docetaxel—head and neck cancer	7.12e-05	0.00168	CcSEcCtD
Cisplatin—BCHE—thyroid gland—head and neck cancer	6.94e-05	0.0026	CbGeAlD
Cisplatin—Nausea—Hydroxyurea—head and neck cancer	6.91e-05	0.00163	CcSEcCtD
Cisplatin—Feeling abnormal—Fluorouracil—head and neck cancer	6.9e-05	0.00162	CcSEcCtD
Cisplatin—Anaemia—Docetaxel—head and neck cancer	6.84e-05	0.00161	CcSEcCtD
Cisplatin—CYP2B6—lymphoid tissue—head and neck cancer	6.82e-05	0.00255	CbGeAlD
Cisplatin—PTGS2—trachea—head and neck cancer	6.76e-05	0.00253	CbGeAlD
Cisplatin—ABCG2—thyroid gland—head and neck cancer	6.71e-05	0.00252	CbGeAlD
Cisplatin—Leukopenia—Docetaxel—head and neck cancer	6.63e-05	0.00156	CcSEcCtD
Cisplatin—Body temperature increased—Fluorouracil—head and neck cancer	6.62e-05	0.00156	CcSEcCtD
Cisplatin—Convulsion—Docetaxel—head and neck cancer	6.41e-05	0.00151	CcSEcCtD
Cisplatin—Myalgia—Docetaxel—head and neck cancer	6.3e-05	0.00148	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.26e-05	0.00147	CcSEcCtD
Cisplatin—Hypersensitivity—Fluorouracil—head and neck cancer	6.17e-05	0.00145	CcSEcCtD
Cisplatin—BCHE—head—head and neck cancer	6.16e-05	0.00231	CbGeAlD
Cisplatin—Anaphylactic shock—Docetaxel—head and neck cancer	6.04e-05	0.00142	CcSEcCtD
Cisplatin—Oedema—Docetaxel—head and neck cancer	6.04e-05	0.00142	CcSEcCtD
Cisplatin—Infection—Docetaxel—head and neck cancer	6e-05	0.00141	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—head and neck cancer	5.92e-05	0.0014	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—head and neck cancer	5.91e-05	0.00139	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—head and neck cancer	5.9e-05	0.00139	CcSEcCtD
Cisplatin—PTGS2—lymphoid tissue—head and neck cancer	5.89e-05	0.00221	CbGeAlD
Cisplatin—Skin disorder—Docetaxel—head and neck cancer	5.87e-05	0.00138	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—head and neck cancer	5.76e-05	0.00136	CcSEcCtD
Cisplatin—Diarrhoea—Fluorouracil—head and neck cancer	5.73e-05	0.00135	CcSEcCtD
Cisplatin—ABCC2—lymph node—head and neck cancer	5.72e-05	0.00214	CbGeAlD
Cisplatin—Hypotension—Docetaxel—head and neck cancer	5.64e-05	0.00133	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.5e-05	0.0013	CcSEcCtD
Cisplatin—CYP2B6—head—head and neck cancer	5.49e-05	0.00206	CbGeAlD
Cisplatin—Paraesthesia—Docetaxel—head and neck cancer	5.42e-05	0.00128	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—head and neck cancer	5.39e-05	0.00127	CcSEcCtD
Cisplatin—Vomiting—Fluorouracil—head and neck cancer	5.32e-05	0.00125	CcSEcCtD
Cisplatin—Rash—Fluorouracil—head and neck cancer	5.28e-05	0.00124	CcSEcCtD
Cisplatin—Dermatitis—Fluorouracil—head and neck cancer	5.27e-05	0.00124	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—head and neck cancer	5.25e-05	0.00124	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.21e-05	0.00123	CcSEcCtD
Cisplatin—Pain—Docetaxel—head and neck cancer	5.17e-05	0.00122	CcSEcCtD
Cisplatin—Feeling abnormal—Docetaxel—head and neck cancer	4.98e-05	0.00117	CcSEcCtD
Cisplatin—Nausea—Fluorouracil—head and neck cancer	4.97e-05	0.00117	CcSEcCtD
Cisplatin—Body temperature increased—Docetaxel—head and neck cancer	4.78e-05	0.00112	CcSEcCtD
Cisplatin—PTGS2—head—head and neck cancer	4.75e-05	0.00178	CbGeAlD
Cisplatin—ABCB1—epithelium—head and neck cancer	4.73e-05	0.00177	CbGeAlD
Cisplatin—Hypersensitivity—Docetaxel—head and neck cancer	4.45e-05	0.00105	CcSEcCtD
Cisplatin—Asthenia—Docetaxel—head and neck cancer	4.33e-05	0.00102	CcSEcCtD
Cisplatin—BCHE—lymph node—head and neck cancer	4.31e-05	0.00162	CbGeAlD
Cisplatin—ABCB1—trachea—head and neck cancer	4.18e-05	0.00157	CbGeAlD
Cisplatin—ABCG2—lymph node—head and neck cancer	4.17e-05	0.00156	CbGeAlD
Cisplatin—Diarrhoea—Docetaxel—head and neck cancer	4.13e-05	0.000973	CcSEcCtD
Cisplatin—Vomiting—Docetaxel—head and neck cancer	3.84e-05	0.000905	CcSEcCtD
Cisplatin—Rash—Docetaxel—head and neck cancer	3.81e-05	0.000897	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—head and neck cancer	3.81e-05	0.000896	CcSEcCtD
Cisplatin—ABCB1—lymphoid tissue—head and neck cancer	3.64e-05	0.00137	CbGeAlD
Cisplatin—Nausea—Docetaxel—head and neck cancer	3.59e-05	0.000845	CcSEcCtD
Cisplatin—PTGS2—lymph node—head and neck cancer	3.32e-05	0.00125	CbGeAlD
Cisplatin—ABCB1—thyroid gland—head and neck cancer	3.31e-05	0.00124	CbGeAlD
Cisplatin—ABCB1—head—head and neck cancer	2.94e-05	0.0011	CbGeAlD
Cisplatin—ABCB1—lymph node—head and neck cancer	2.06e-05	0.00077	CbGeAlD
Cisplatin—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	1.29e-05	0.000323	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.28e-05	0.000319	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.27e-05	0.000316	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2—head and neck cancer	1.26e-05	0.000315	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	1.26e-05	0.000315	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—DPYD—head and neck cancer	1.24e-05	0.00031	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.24e-05	0.000309	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.21e-05	0.000303	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	1.21e-05	0.000303	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—head and neck cancer	1.21e-05	0.000302	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.21e-05	0.000301	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NAT2—head and neck cancer	1.2e-05	0.000301	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	1.19e-05	0.000298	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.18e-05	0.000296	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—YAP1—head and neck cancer	1.18e-05	0.000294	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2—head and neck cancer	1.16e-05	0.000291	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.16e-05	0.000291	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	1.15e-05	0.000287	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000286	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—MAPK3—head and neck cancer	1.14e-05	0.000286	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	1.13e-05	0.000283	CbGpPWpGaD
Cisplatin—BCHE—Phospholipid metabolism—PIK3CA—head and neck cancer	1.1e-05	0.000275	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PTEN—head and neck cancer	1.1e-05	0.000274	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—MAPK1—head and neck cancer	1.09e-05	0.000272	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GPX1—head and neck cancer	1.08e-05	0.000271	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—UROD—head and neck cancer	1.08e-05	0.00027	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CYP1A1—head and neck cancer	1.07e-05	0.000268	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.07e-05	0.000268	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—DPYD—head and neck cancer	1.06e-05	0.000264	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	1.04e-05	0.00026	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	1.04e-05	0.000259	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—UROD—head and neck cancer	1.01e-05	0.000252	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—YAP1—head and neck cancer	1e-05	0.00025	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.98e-06	0.000249	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—head and neck cancer	9.9e-06	0.000247	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	9.88e-06	0.000247	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	9.88e-06	0.000247	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT3—head and neck cancer	9.8e-06	0.000245	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.77e-06	0.000244	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—TYMS—head and neck cancer	9.74e-06	0.000243	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.67e-06	0.000242	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GSTM1—head and neck cancer	9.62e-06	0.00024	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—TYMS—head and neck cancer	9.49e-06	0.000237	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—PIK3CA—head and neck cancer	9.44e-06	0.000236	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	9.41e-06	0.000235	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSTM1—head and neck cancer	9.38e-06	0.000234	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MAPK3—head and neck cancer	9.36e-06	0.000234	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GPX1—head and neck cancer	9.22e-06	0.00023	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NAT2—head and neck cancer	9.2e-06	0.00023	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—head and neck cancer	9.13e-06	0.000228	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CYP1A1—head and neck cancer	9.12e-06	0.000228	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GPX1—head and neck cancer	8.98e-06	0.000224	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MAPK1—head and neck cancer	8.9e-06	0.000223	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—head and neck cancer	8.9e-06	0.000222	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CYP1A1—head and neck cancer	8.89e-06	0.000222	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.85e-06	0.000221	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—head and neck cancer	8.73e-06	0.000218	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTEN—head and neck cancer	8.64e-06	0.000216	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	8.56e-06	0.000214	CbGpPWpGaD
Cisplatin—XDH—Metabolism—TYMS—head and neck cancer	8.51e-06	0.000213	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTM1—head and neck cancer	8.41e-06	0.00021	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	8.4e-06	0.00021	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NAT2—head and neck cancer	8.3e-06	0.000207	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	8.29e-06	0.000207	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	8.27e-06	0.000207	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.24e-06	0.000206	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NAT2—head and neck cancer	8.21e-06	0.000205	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—TYMS—head and neck cancer	8.16e-06	0.000204	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTM1—head and neck cancer	8.07e-06	0.000202	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—DPYD—head and neck cancer	8.07e-06	0.000202	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GPX1—head and neck cancer	8.06e-06	0.000201	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP1A1—head and neck cancer	7.97e-06	0.000199	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.9e-06	0.000197	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.83e-06	0.000196	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PIK3CA—head and neck cancer	7.73e-06	0.000193	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GPX1—head and neck cancer	7.72e-06	0.000193	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.72e-06	0.000193	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—head and neck cancer	7.71e-06	0.000193	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—YAP1—head and neck cancer	7.65e-06	0.000191	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP1A1—head and neck cancer	7.65e-06	0.000191	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	7.56e-06	0.000189	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.53e-06	0.000188	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.47e-06	0.000187	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOTCH1—head and neck cancer	7.31e-06	0.000183	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—DPYD—head and neck cancer	7.28e-06	0.000182	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MAPK1—head and neck cancer	7.21e-06	0.00018	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—DPYD—head and neck cancer	7.2e-06	0.00018	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—head and neck cancer	7.15e-06	0.000179	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—TYMS—head and neck cancer	7.07e-06	0.000177	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.07e-06	0.000177	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.06e-06	0.000176	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTM1—head and neck cancer	6.99e-06	0.000175	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—YAP1—head and neck cancer	6.91e-06	0.000173	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—YAP1—head and neck cancer	6.84e-06	0.000171	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	6.75e-06	0.000169	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.72e-06	0.000168	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.72e-06	0.000168	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.72e-06	0.000168	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.72e-06	0.000168	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GPX1—head and neck cancer	6.7e-06	0.000167	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.66e-06	0.000166	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP1A1—head and neck cancer	6.63e-06	0.000166	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.56e-06	0.000164	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MAPK1—head and neck cancer	6.44e-06	0.000161	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—head and neck cancer	6.38e-06	0.000159	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NAT2—head and neck cancer	6.33e-06	0.000158	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—head and neck cancer	6.31e-06	0.000158	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—head and neck cancer	6.09e-06	0.000152	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NAT2—head and neck cancer	6.08e-06	0.000152	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.07e-06	0.000152	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TYMS—head and neck cancer	6.02e-06	0.00015	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTM1—head and neck cancer	5.95e-06	0.000149	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.86e-06	0.000146	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.83e-06	0.000146	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—head and neck cancer	5.79e-06	0.000145	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.75e-06	0.000144	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GPX1—head and neck cancer	5.69e-06	0.000142	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.64e-06	0.000141	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP1A1—head and neck cancer	5.64e-06	0.000141	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—head and neck cancer	5.56e-06	0.000139	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—DPYD—head and neck cancer	5.55e-06	0.000139	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.45e-06	0.000136	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—head and neck cancer	5.43e-06	0.000136	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—head and neck cancer	5.43e-06	0.000136	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—DPYD—head and neck cancer	5.34e-06	0.000133	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.29e-06	0.000132	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—head and neck cancer	5.29e-06	0.000132	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—YAP1—head and neck cancer	5.27e-06	0.000132	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—head and neck cancer	5.17e-06	0.000129	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—YAP1—head and neck cancer	5.06e-06	0.000127	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.01e-06	0.000125	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.01e-06	0.000125	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—head and neck cancer	4.98e-06	0.000124	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.76e-06	0.000119	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.76e-06	0.000119	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.76e-06	0.000119	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—head and neck cancer	4.74e-06	0.000119	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—head and neck cancer	4.73e-06	0.000118	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—head and neck cancer	4.73e-06	0.000118	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.63e-06	0.000116	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—head and neck cancer	4.61e-06	0.000115	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TYMS—head and neck cancer	4.6e-06	0.000115	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—head and neck cancer	4.55e-06	0.000114	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—head and neck cancer	4.54e-06	0.000114	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NAT2—head and neck cancer	4.49e-06	0.000112	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.45e-06	0.000111	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.41e-06	0.00011	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPX1—head and neck cancer	4.35e-06	0.000109	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A1—head and neck cancer	4.31e-06	0.000108	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—head and neck cancer	4.23e-06	0.000106	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NAT2—head and neck cancer	4.19e-06	0.000105	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TYMS—head and neck cancer	4.15e-06	0.000104	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—head and neck cancer	4.14e-06	0.000103	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.13e-06	0.000103	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TYMS—head and neck cancer	4.1e-06	0.000103	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—head and neck cancer	4.1e-06	0.000102	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—head and neck cancer	4.06e-06	0.000101	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—head and neck cancer	4.05e-06	0.000101	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4e-06	9.99e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—head and neck cancer	3.97e-06	9.91e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—head and neck cancer	3.94e-06	9.85e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—DPYD—head and neck cancer	3.94e-06	9.83e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—head and neck cancer	3.93e-06	9.81e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPX1—head and neck cancer	3.93e-06	9.81e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A1—head and neck cancer	3.89e-06	9.71e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPX1—head and neck cancer	3.89e-06	9.71e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK1—head and neck cancer	3.85e-06	9.62e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—head and neck cancer	3.85e-06	9.62e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A1—head and neck cancer	3.85e-06	9.61e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—YAP1—head and neck cancer	3.73e-06	9.33e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—DPYD—head and neck cancer	3.68e-06	9.19e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.54e-06	8.84e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—YAP1—head and neck cancer	3.49e-06	8.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.45e-06	8.63e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—head and neck cancer	3.44e-06	8.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.38e-06	8.44e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—head and neck cancer	3.35e-06	8.38e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—head and neck cancer	3.34e-06	8.35e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—head and neck cancer	3.34e-06	8.34e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—head and neck cancer	3.25e-06	8.13e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—head and neck cancer	3.21e-06	8.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—head and neck cancer	3.16e-06	7.9e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—head and neck cancer	3.13e-06	7.81e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—head and neck cancer	3.09e-06	7.72e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—head and neck cancer	3.04e-06	7.6e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—head and neck cancer	3.01e-06	7.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX1—head and neck cancer	2.99e-06	7.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.96e-06	7.41e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—head and neck cancer	2.92e-06	7.3e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—head and neck cancer	2.92e-06	7.29e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX1—head and neck cancer	2.88e-06	7.19e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.85e-06	7.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—head and neck cancer	2.83e-06	7.08e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—head and neck cancer	2.8e-06	6.99e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—head and neck cancer	2.73e-06	6.82e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—head and neck cancer	2.73e-06	6.81e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—head and neck cancer	2.66e-06	6.64e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.62e-06	6.55e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—head and neck cancer	2.56e-06	6.4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.44e-06	6.09e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—head and neck cancer	2.43e-06	6.06e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—head and neck cancer	2.38e-06	5.96e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—head and neck cancer	2.31e-06	5.78e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—head and neck cancer	2.29e-06	5.72e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.29e-06	5.71e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—head and neck cancer	2.29e-06	5.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—head and neck cancer	2.24e-06	5.6e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—head and neck cancer	2.23e-06	5.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—head and neck cancer	2.22e-06	5.54e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX1—head and neck cancer	2.12e-06	5.3e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.1e-06	5.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—head and neck cancer	2.09e-06	5.23e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.07e-06	5.17e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—head and neck cancer	2.06e-06	5.15e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—head and neck cancer	2.02e-06	5.04e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—head and neck cancer	1.99e-06	4.98e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX1—head and neck cancer	1.98e-06	4.95e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—head and neck cancer	1.98e-06	4.95e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.96e-06	4.9e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—head and neck cancer	1.84e-06	4.59e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.69e-06	4.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—head and neck cancer	1.68e-06	4.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—head and neck cancer	1.64e-06	4.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.61e-06	4.03e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—head and neck cancer	1.58e-06	3.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—head and neck cancer	1.57e-06	3.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—head and neck cancer	1.54e-06	3.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK1—head and neck cancer	1.49e-06	3.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—head and neck cancer	1.49e-06	3.73e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—head and neck cancer	1.48e-06	3.69e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.42e-06	3.55e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—head and neck cancer	1.41e-06	3.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—head and neck cancer	1.29e-06	3.24e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—head and neck cancer	1.29e-06	3.22e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—head and neck cancer	1.25e-06	3.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—head and neck cancer	1.2e-06	2.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.17e-06	2.92e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—head and neck cancer	1.16e-06	2.9e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—head and neck cancer	1.15e-06	2.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—head and neck cancer	1.09e-06	2.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.08e-06	2.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—head and neck cancer	1.06e-06	2.64e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.04e-06	2.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—head and neck cancer	1.02e-06	2.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—head and neck cancer	8.86e-07	2.21e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—head and neck cancer	8.51e-07	2.13e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.69e-07	1.92e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.18e-07	1.79e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—head and neck cancer	6.28e-07	1.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—head and neck cancer	5.87e-07	1.47e-05	CbGpPWpGaD
